Genovis Finds Second China Distribution Partner for Enzyme Portfolio

03:05 EST 10 Nov 2017 | ChinaBio Today

Genovis, a Swedish enzyme company, signed a China distribution agreement with Shanghai Titan Scientific. Genovis sells a portfolio of enzymes, which it calls SmartEnzymes, that facilitate development and quality control of biological drugs. In September, Genovis announced a distribution pact with Beijing Zhongyuan Ltd., its first foray into the China market. The company sells its products worldwide. No financial details of the China agreements were disclosed. More details....

Original Article: Genovis Finds Second China Distribution Partner for Enzyme Portfolio


More From BioPortfolio on "Genovis Finds Second China Distribution Partner for Enzyme Portfolio"

Quick Search


Relevant Topics

Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...